Could molecular prosthetics lead to drugs for all cystic fibrosis patients? - An interview with Martin Burke
We recently reported on research looking into repurposing amphotericin, a drug approved to treat fungal infections, to treat patients with cystic fibrosis. In this interview, with Martin Burke (University of Illinois; USA), get a deeper dive into this research that led up to this discovery.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>